Search scope:
排序: Display mode:
Kai Qu,Ting Lin,Zhixin Wang,Sinan Liu,Hulin Chang,Xinsen Xu,Fandi Meng,Lei Zhou,Jichao Wei,Minghui Tai,Yafeng Dong,Chang Liu
Frontiers of Medicine 2014, Volume 8, Issue 2, Pages 227-235 doi: 10.1007/s11684-014-0327-1
Accelerated senescence is important because this process is involved in tumor suppression and hasHowever, the molecular mechanism of cisplatin-induced accelerated senescence in hepatocellular carcinomaCellular senescence was then assessed by β-galactosidase assay.Furthermore, cisplatin-induced accelerated senescence depended on intracellular ROS generation.The ROS scavenger N-acetyl-L-cysteine also significantly suppressed the cisplatin-induced senescence
Keywords: reactive oxygen species senescence cisplatin hepatocellular carcinoma
Tian Wang, Yan Li, Abidan Tuerhanjiang, Wenwen Wang, Zhangying Wu, Ming Yuan, Shixuan Wang
Frontiers of Medicine 2014, Volume 8, Issue 1, Pages 106-112 doi: 10.1007/s11684-014-0307-5
Keywords: cervical cancer senescence Twist CBX3 lymph node metastasis
Biqiong Fu, Jie Yang, Jia Chen, Lirong Lin, Kehong Chen, Weiwei Zhang, Jianguo Zhang, Yani He
Frontiers of Medicine 2019, Volume 13, Issue 2, Pages 267-276 doi: 10.1007/s11684-017-0586-8
Keywords: Shenkang injection senescence renal tubular epithelial cells diabetic nephropathy
Taking advantage of drug resistance, a new approach in the war on cancer
Liqin Wang, Rene Bernards
Frontiers of Medicine 2018, Volume 12, Issue 4, Pages 490-495 doi: 10.1007/s11684-018-0647-7
Identification of the driver mutations in cancer has resulted in the development of a new category of molecularly targeted anti-cancer drugs. However, as was the case with conventional chemotherapies, the effectiveness of these drugs is limited by the emergence of drug-resistant variants. While most cancer therapies are given in combinations that are designed to avoid drug resistance, we discuss here therapeutic approaches that take advantage of the changes in cancer cells that arise upon development of drug resistance. This approach is based on notion that drug resistance comes at a fitness cost to the cancer cell that can be exploited for therapeutic benefit. We discuss the development of sequential drug therapies in which the first therapy is not given with curative intent, but to induce a major new sensitivity that can be targeted with a second drug that selectively targets the acquired vulnerability. This concept of collateral sensitivity has hitherto not been used on a large scale in the clinic and holds great promise for future cancer therapy.
Keywords: cancer drug resistance genetic screens senescence targeted therapy
ECRG4: a new potential target in precision medicine
Xin Qin, Ping Zhang
Frontiers of Medicine 2019, Volume 13, Issue 5, Pages 540-546 doi: 10.1007/s11684-018-0637-9
Keywords: ECRG4 tumor suppressor gene sentinel molecule precision medicine cell senescence epithelium homeostasis
Qi RUI, Qin LU, Dayong WANG
Frontiers of Medicine 2009, Volume 3, Issue 1, Pages 76-90 doi: 10.1007/s11684-009-0002-0
Keywords:
Title Author Date Type Operation
Reactive oxygen species generation is essential for cisplatin-induced accelerated senescence in hepatocellular
Kai Qu,Ting Lin,Zhixin Wang,Sinan Liu,Hulin Chang,Xinsen Xu,Fandi Meng,Lei Zhou,Jichao Wei,Minghui Tai,Yafeng Dong,Chang Liu
Journal Article
Correlation of Twist upregulation and senescence bypass during the progression and metastasis of cervical
Tian Wang, Yan Li, Abidan Tuerhanjiang, Wenwen Wang, Zhangying Wu, Ming Yuan, Shixuan Wang
Journal Article
Preventive effect of Shenkang injection against high glucose-induced senescence of renal tubular cells
Biqiong Fu, Jie Yang, Jia Chen, Lirong Lin, Kehong Chen, Weiwei Zhang, Jianguo Zhang, Yani He
Journal Article
Taking advantage of drug resistance, a new approach in the war on cancer
Liqin Wang, Rene Bernards
Journal Article